Skip to main content
. 2026 May 24;16(6):279. doi: 10.3390/jpm16060279
ANOVA analysis of variance
CA9 carbonic anhydrase 9
ccRCC clear cell renal cell carcinoma
CDH1 cadherin 1 (E-cadherin)
CDH2 cadherin 2 (N-cadherin)
CI confidence interval
CTNNB1 catenin beta 1 (β-catenin)
DAPI 4′,6-diamidino-2-phenylindole
DFS disease-free survival
EMT epithelial–mesenchymal transition
EMT-TF EMT-inducing transcription factor
FFPE formalin-fixed, paraffin-embedded
GEPIA Gene Expression Profiling Interactive Analysis
GTEx Genotype-Tissue Expression
H&E hematoxylin and eosin
HIF1A hypoxia-inducible factor 1 subunit alpha
HR hazard ratio
KIRC kidney renal clear cell carcinoma
OS overall survival
PBS phosphate-buffered saline
PCDH9 protocadherin 9
PFA paraformaldehyde
PFI progression-free interval
SD standard deviation
SNAI1 snail family transcriptional repressor 1
SNAI2 snail family transcriptional repressor 2
TCGA The Cancer Genome Atlas
TPM transcripts per million
VHL von Hippel–Lindau
VIM vimentin
WHO/ISUP World Health Organization/International Society of Urological Pathology
ZEB1 zinc finger E-box binding homeobox 1
ZEB2 zinc finger E-box binding homeobox 2